Parallax Volatility Advisers’s Idexx Laboratories IDXX Stock Holding History

Parallax Volatility Advisers’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,500	Closed	-$526K	–	3219
2022 Q2	$526K	Buy	+1,500	New	+$612K	﹤0.01%	1892
2021 Q1	–	Sell	-1,200	Closed	-$600K	–	1574
2020 Q4	$600K	Sell	1,200 -1,300	-52%	-$582K	﹤0.01%	1611
2020 Q3	$982K	Buy	2,500 +1,300	+108%	+$481K	﹤0.01%	1991
2020 Q2	$396K	Hold	1,200	–	–	﹤0.01%	2047
2020 Q1	$290K	Sell	1,200 -3,300	-73%	-$861K	﹤0.01%	1900
2019 Q4	$1.18M	Buy	+4,500	New	+$1.19M	﹤0.01%	1459
2016 Q4	–	Sell	-3,200	Closed	-$361K	–	3535
2016 Q3	$361K	Sell	3,200 -29,300	-90%	-$3.09M	﹤0.01%	1611
2016 Q2	$3.02M	Buy	+32,500	New	+$2.79M	0.01%	787
2015 Q4	–	Sell	-70,000	Closed	-$5.2M	–	3331
2015 Q3	$5.2M	Buy	+70,000	New	+$5.01M	0.01%	662

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parallax Volatility Advisers's IDXX Position: Q4 2024 in Review

Parallax Volatility Advisers sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 6,472 shares — an estimated $3.27M sold.

Parallax Volatility Advisers first reported a position in IDXX in Q2 2015 and held it in 17 quarters. The position peaked at $3.27M in Q3 2024. 1,124 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

Parallax Volatility Advisers reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
Parallax Volatility Advisers sold 6,472 Idexx Laboratories shares in Q4 2024, an estimated $3.27M.
Parallax Volatility Advisers first reported a position in Idexx Laboratories in Q2 2015 and held it in 17 quarters.
Parallax Volatility Advisers's Idexx Laboratories position peaked at $3.27M in Q3 2024.
1,124 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Parallax Volatility Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.